Research ArticleCancer

Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment

See allHide authors and affiliations

Science Translational Medicine  09 Mar 2016:
Vol. 8, Issue 329, pp. 329ra34
DOI: 10.1126/scitranslmed.aad5653
PDF Container

Stay Connected to Science Translational Medicine

Navigate This Article